Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Leerink Partners Lowers Cardinal Health (NYSE:CAH) Rating to “Mkt Perform” from “Outperform”

London Cardinal Health NYSE:CAH

Cardinal Health (NYSE:CAH) Downgrade of Rating

Leerink Partners cut Cardinal Health (NYSE:CAH)’s stock to “Mkt Perform” rating from “Outperform”. The rating change was shared with investors in a note today.

Out of 15 analysts covering Cardinal Health, 12 rate it a Buy, 7 indicate a Hold while 0 suggest a Sell. The highest target is $107 and the lowest is $83 according to Thomson/First Call. The 12-month mean target is $91.93, which means upside potential of 25.04% over the current price.

Institutional Ownership

Healthinvest Partners Ab had the largest stake with ownership of 230,800 shares as of Q2 2015 for 13.34% of the fund portfolio. Dsc Advisors L.P. is another bullish fund who is possessing 180,220 shares of Cardinal Health or 8.51% of their fund portfolio. Also, Sio Capital Management Llc have 7.18% of their fund portfolio invested in the company for 133,937 shares. The California-based fund Mcdonald Capital Investors Inc Ca disclosed it had purchased so far a stake worth about 5.58% of the fund’s stock portfolio in Cardinal Health. The New York-based fund Rr Partners Lp is also positive about the stock, possessing 755,740 shares or 4.52% of their fund portfolio.

Cardinal Health (NYSE:CAH) Profile

Cardinal Health IncCardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products.

Cardinal Health (NYSE:CAH) traded down -0.24% on 21 December, hitting $73.52. A total of 1.11 million shares of the company’s stock traded hands. This is down from average of 3.40 million shares. Cardinal Health has a 52 week low of $62.70 and a 52 week high of $91.22. The company has a market cap of $23.51 billion and a P/E ratio of 17.83.

Get the latest Cardinal Health (NYSE:CAH) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post Leerink Partners Lowers Cardinal Health (NYSE:CAH) Rating to “Mkt Perform” from “Outperform” appeared first on Octafinance.

This post first appeared on Octafinance – Financial News, Reports And Intell, please read the originial post: here

Share the post

Leerink Partners Lowers Cardinal Health (NYSE:CAH) Rating to “Mkt Perform” from “Outperform”


Subscribe to Octafinance – Financial News, Reports And Intell

Get updates delivered right to your inbox!

Thank you for your subscription